Lipid-based nanoparticles for delivery of vaccine adjuvants and antigens: toward multicomponent vaccines

D Chatzikleanthous, DT O'Hagan… - Molecular …, 2021 - ACS Publications
Despite the many advances that have occurred in the field of vaccine adjuvants, there are
still unmet needs that may enable the development of vaccines suitable for more …

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight

H Jamshaid, FU Din, GM Khan - Journal of Nanobiotechnology, 2021 - Springer
As a neglected tropical disease, Leishmaniasis is significantly instigating morbidity and
mortality across the globe. Its clinical spectrum varies from ulcerative cutaneous lesions to …

[HTML][HTML] Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis–A review

P Prasanna, P Kumar, S Kumar, VK Rajana… - Biomedicine & …, 2021 - Elsevier
The study of tropical diseases like leishmaniasis, a parasitic disease, has not received much
attention even though it is the second-largest infectious disease after malaria. As per the …

[HTML][HTML] An overview of the treatment of cutaneous leishmaniasis

TF Garza-Tovar, MI Sacriste-Hernández… - Faculty …, 2020 - ncbi.nlm.nih.gov
Leishmaniasis is a neglected tropical disease caused by species of Leishmania, with a
broad spectrum of clinical manifestations, such as cutaneous, visceral, and mucocutaneous …

The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis

Z Abpeikar, M Safaei, AA Alizadeh, A Goodarzi… - International Journal of …, 2023 - Elsevier
Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis

O Kammona, E Tsanaktsidou - International Journal of Pharmaceutics, 2021 - Elsevier
Leishmaniasis is a prevalent parasitic infection belonging to neglected tropical diseases. It is
caused by Leishmania protozoan parasites transmitted by sandflies and it is responsible for …

Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation

F Bayat, R Hosseinpour-Moghadam, F Mehryab… - Advances in colloid and …, 2020 - Elsevier
Liposomes, lipid-based vesicular systems, have attracted major interest as a means to
improve drug delivery to various organs and tissues in the human body. Recent literature …

[HTML][HTML] TLR7 sensing by neutrophils is critical for the control of cutaneous leishmaniasis

IB Regli, K Passelli, B Martínez-Salazar, J Amore… - Cell reports, 2020 - cell.com
Neutrophils are rapidly recruited to sites of infection, where they kill invading pathogens.
However, they may also act as early temporary shelters, favoring subsequent pathogen …

[HTML][HTML] Chlorella vulgaris extract and Imiquimod as new therapeutic targets for leishmaniasis: An immunological approach

MGN de Melo, IBSM Reino, V Vaitkevicius-Antão… - Immunobiology, 2024 - Elsevier
The therapeutic regimen for the treatment of American Tegumentary Leishmaniasis (ATL) is
targeted at the death of the parasite; therefore, it is essential to develop a treatment that can …

Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease-An update overview

JP Assolini, ACM Carloto, BT da Silva Bortoleti… - European Journal of …, 2022 - Elsevier
Leishmaniasis is a neglected tropical disease that has a wide spectrum of clinical
manifestations, ranging from visceral to cutaneous, with millions of new cases and …